Navigation Links
Jazz Pharmaceuticals Announces Third Quarter 2012 Results
Date:11/8/2012

quarter of 2012 were $13.4 million. These products include other non-promoted products acquired in the EUSA Pharma and Azur Pharma transactions. 

Other Financial Highlights

  • Cost of product sales increased by $28.7 million compared to the third quarter of 2011 due to higher net sales and $10.3 million of purchase accounting inventory fair value step-up.
  • Selling, general and administrative expenses increased by $30.4 million compared to the prior year quarter, primarily due to increased headcount and related expenses from the addition of the Azur Pharma and EUSA Pharma businesses.
  • Intangible asset amortization for the third quarter of 2012 was $19.7 million, related primarily to the company's expanded product portfolio.
  • Interest expense increased by $7.6 million compared to the third quarter of 2011 due to inclusion of a full quarter's interest under the company's term loan which had a balance of $462.3 million as of September 30, 2012.
  • Recent Transaction and Balance Sheet UpdateOn October 15, 2012, Jazz Pharmaceuticals completed the sale of its women's health business to Meda for $97.6 million in cash, including $2.6 million for certain purchased inventory.  Following this transaction, Jazz Pharmaceuticals has approximately $300 million in cash and cash equivalents.

    2012 Financial GuidanceJazz Pharmaceuticals is providing 2012 guidance for continuing operations which reflects the sale of its women's health business and the treatment of that business as a discontinued operation.  2012 Guidance for
    Continuing OperationsRevenues

    $575-585 millionTotal Net Product Sales$570-580 million-Xyrem Net Sales

    $375-380 million-Erwinaze/Erwinase Net Sales (partial year)1

    $65-69 millionAdjusted Gross Margin %2

    88-91%Adjusted Combined SG&A and R&D Expenses3

    $200-205 millionGAAP Income from Continuing Operations$140-
    '/>"/>

    SOURCE Jazz Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related medicine technology :

    1. Harwood Feffer LLP Announces Investigation of DUSA Pharmaceuticals, Inc.
    2. Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
    3. Isis Pharmaceuticals To Present At The 2012 Credit Suisse Healthcare Conference
    4. Savient Pharmaceuticals Reports Third Quarter 2012 Financial Results
    5. Genoa Pharmaceuticals announces $1.2M Financing
    6. Inovio Pharmaceuticals Reports 2012 Third Quarter Financial Results
    7. Arisaph Pharmaceuticals Reports Positive Results From Two Safety Clinical Trials For Its Niacin Analog (ARI-3037MO)
    8. Oramed Pharmaceuticals to Present at the 12th Annual Diabetes Technology Society Meeting in Bethesda, MD, Nov 8-10, 2012
    9. Optimer Pharmaceuticals to Present at November 2012 Investor Conferences
    10. Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2012 Financial Results
    11. Isis Pharmaceuticals To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/6/2015)... MENLO PARK, Calif. , May 6, 2015 ... a leading biotechnology company in the emerging field ... will host a meeting with the investment community ... (oligodendrocyte progenitor cells) in spinal cord injury on ... current Phase 1/2a clinical trial and future planned ...
    (Date:5/6/2015)... Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) ... 31, 2015.  The net loss and the loss from ... $13.0 million, respectively, compared to $10.7 million and $8.8 ... March 31, 2015, Alexza had consolidated cash, cash equivalents, ... "We continue to focus on ways in which ...
    (Date:5/6/2015)... , May 6, 2015 /CNW/ - Celebrities, bloggers and influencers ... social media to spread the important message that melanoma prevention ... protection. Maria Sharapova , Hilary Duff , and ... who reached out to their networks on Monday to share ... to watch The David Cornfield Melanoma Fund ...
    Breaking Medicine Technology:Asterias Biotherapeutics to Host Investor Meeting to Review Clinical Development Strategy for AST-OPC1 in Spinal Cord Injury 2Asterias Biotherapeutics to Host Investor Meeting to Review Clinical Development Strategy for AST-OPC1 in Spinal Cord Injury 3Alexza Reports 2015 First Quarter Financial Results 2Alexza Reports 2015 First Quarter Financial Results 3Alexza Reports 2015 First Quarter Financial Results 4Alexza Reports 2015 First Quarter Financial Results 5Alexza Reports 2015 First Quarter Financial Results 6Alexza Reports 2015 First Quarter Financial Results 7Alexza Reports 2015 First Quarter Financial Results 8Alexza Reports 2015 First Quarter Financial Results 9Alexza Reports 2015 First Quarter Financial Results 10Celebrities Tweet Their Support of Melanoma Awareness Month and #newfamilyrule 2
    ... , , , ... clinical stage biopharmaceutical company announced today the presentation of "Results ... T-Cell receptor ligand specific for an immunodominant MOG peptide, in ... Artielle,s founding scientists, Arthur Vandenbark, Ph.D., at the Congress of ...
    ... , , FRANKLIN, ... a company focused on innovative cardiac and vascular medical device-based technologies, ... Transmyocardial Laser Revascularization (TMR) therapy in conjunction with autologous stem cells ... European Society of Cardiology, in Barcelona, Spain. , ...
    Cached Medicine Technology:Artielle ImmunoTherapeutics Announces Positive Results of Phase 1 Multiple Sclerosis Trial 2Artielle ImmunoTherapeutics Announces Positive Results of Phase 1 Multiple Sclerosis Trial 3Study on PLC Systems' TMR Therapy With Stem Cells Presented at ESC 2009 2Study on PLC Systems' TMR Therapy With Stem Cells Presented at ESC 2009 3
    (Date:5/6/2015)... Animals make just as good friends as they do pets. ... An Ohio veterinarian has been observing this for ... advantages of owning a pet. , “When animals and humans ... there are proven health benefits for people-- including physical, mental ... Animal Medical Center of Streetsboro said. Every May, ...
    (Date:5/6/2015)... Columbus, OH (PRWEB) May 06, 2015 ... practice at Hematology Oncology Consultants, Inc. in Columbus, ... cancers and has a special focus in breast cancer, lung ... myeloma and lymphoma as well as benign hematology. ... hematology and internal medicine by the American Board of Internal ...
    (Date:5/6/2015)... 2015 Anitoa Systems, (“Anitoa”), a Palo ... University of China, has successfully demonstrated a handheld real ... sensor. Anitoa’s handheld qPCR is shown to be ... RNA’s, including hepatitis B, C, and E. Coli. This ... per sample and over 9 orders of magnitude dynamic ...
    (Date:5/6/2015)... Chandler, AZ (PRWEB) May 06, 2015 ... now open for League Corporate Partner booth selection ... products and services to community college and university decision-makers ... take place November 1-4, 2015, at the Arizona Grand ... a private desert oasis on the doorstep of the ...
    (Date:5/6/2015)... 06, 2015 TransferSoft® Inc. ... of VC funding and launched its HyperTransfer™ data ... embeddable software enables applications to more reliably, efficiently, and ... between systems and locations. Available now for integration into ... at line speed, independent of file size or depth ...
    Breaking Medicine News(10 mins):Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 2Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 3Health News:New Oncologist to Join Hematology Oncology Consultants, Inc. 2Health News:New Oncologist to Join Hematology Oncology Consultants, Inc. 3Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 2Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 3Health News:STEMtech Conference Exhibitors Gain Access to Community College and University Representatives From Across the U.S. 2Health News:TransferSoft Launches Industry’s Most Comprehensive Data Movement Technology Suite to Optimize Disaster Recovery, Big Data, and Cloud Applications 2Health News:TransferSoft Launches Industry’s Most Comprehensive Data Movement Technology Suite to Optimize Disaster Recovery, Big Data, and Cloud Applications 3Health News:TransferSoft Launches Industry’s Most Comprehensive Data Movement Technology Suite to Optimize Disaster Recovery, Big Data, and Cloud Applications 4
    ... HARRISBURG, Pa., July 23 More than 1,000 ... at nearly $160,000, in the second quarter of this year, ... , "These clinics are part of ... those who cannot afford dental care," said Harlon L. Robinson, ...
    ... , MIAMI, July 23 Following a ... and a leader in sports nutrition for over 40 years, continues ... weekend Twinlab,s 2009 Mobile Beach Bash ... Miami, Florida. For those eager to show-off their six-pack abs for ...
    ... SUNRISE, Fla., July 23 Bioheart, Inc. (OTC Bulletin Board: ... that help monitor, diagnose and treat heart failure and cardiovascular ... the Heart Failure Society of America (HFSA) Meeting September 13-16th, ... Chris O,Connor, MD, Head of Heart Failure at Duke ...
    ... of young drivers has shown that risky driving habits ... of crashing, irrespective of their perceptions about road safety. ... crashes reported to police. Young drivers involved in the ... more likely to crash. Previous research ...
    ... Beauty Professionals Encouraged to Share Educational Materials , ... , WASHINGTON, July 23 ... created to help women cope with the appearance-related changes of cancer treatment, ... (NCA) to generate awareness and increase program participation during its 20th anniversary ...
    ... , , SAN DIEGO, July ... today announced that it has priced an underwritten public offering ... of $7.50 per share. Net proceeds, after estimated underwriting discounts ... Orexigen has granted the underwriter a 30-day option to purchase ...
    Cached Medicine News:Health News:More than 1,000 Underinsured and Uninsured Individuals Receive Free Dental Care 2Health News:Twinlab's(R) Mobile Beach Bash Heats Up After a Successful Kick-Off of the 2009 RateYourAbs.com Contest 2Health News:Bioheart Announces Acceptance of Marvel-1 Data for Presentation at the Heart Failure Society of America (HFSA) Meeting 2Health News:Bioheart Announces Acceptance of Marvel-1 Data for Presentation at the Heart Failure Society of America (HFSA) Meeting 3Health News:Risky driving puts P-platers at high danger of crash 2Health News:Look Good...Feel Better Launches Salon Awareness Campaign During National Breast Cancer Awareness Month 2Health News:Look Good...Feel Better Launches Salon Awareness Campaign During National Breast Cancer Awareness Month 3Health News:Orexigen(R) Therapeutics Prices Public Offering of Common Stock 2
    ... combining the corrosion resistance of stainless ... of copper, SANYO offers an electro-polished ... and maintenance-free. The sterile environment promotes ... results and the safety of laboratory ...
    ArcticTemp Upright Freezer -20C. Quick, even freezing. Heavy duty compressor. Deep door racks. Front gated bottom shelf. Interior light. Locks One year warranty on unit and 5 year warranty on compres...
    Undercounter Freezer -25C. White. Front opening freezer. 4 cubic ft capacity. Reversible door. Three slide-out drawers. Extra thick CFC insulation. Front lock. Front indicator lights. Attractive tabl...
    ... highly accurate portable, waterproof system for pH, mV ... pH results can be obtained when used with ... • This GLP/GMP compliant system includes an RS-232 ... computer. Up to 100 data sets can be ...
    Medicine Products: